U.S., Sept. 19 -- ClinicalTrials.gov registry received information related to the study (NCT07179978) titled 'Lorazepam and the Risk of Serious Adverse Events' on Sept. 05.
Brief Summary: This is a population-based cohort study assessing whether initiating a new outpatient prescription of a higher dose of lorazepam (>1-4 mg/day) compared to a lower dose (0.5-1 mg/day) in older adults with low kidney function (an eGFR 1-4 mg/day.
Recruitment Status: COMPLETED
Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Published by HT Digital Content Services with permission from Health Daily Digest....